Articles by Jennifer Markarian - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jennifer Markarian

Second-Quarter 2012 Financial Reports Show Pfizer, Novartis Down; Merck Up

Jul 31, 2012

Pharmaceutical industry leaders Pfizer, Novartis, Merck, and other companies released second-quarter 2012 results, emphasizing growth of new products and strength in emerging markets.

Defining Design Space in Hot-Melt Extrusion

Continuous manufacturing of amorphous solid dispersions in a twin-screw extruder is well-suited to quality by design processes such as defining design space.
Jul 18, 2012

Continuous manufacturing of amorphous solid dispersions in a twin-screw extruder is well-suited to quality by design processes such as defining design space.

IMS Institute for Healthcare Informatics Issues Forecast for Global Medicine Use

Jul 16, 2012

Global spending on medicines is estimated to reach nearly $1.2 trillion by 2016.

ISPE Issues Guidance for Packaging, Labeling, and Warehousing Facilities

Jul 9, 2012

ISPE has issued a guidance that is intended to help companies meet cGMP requirements for packaging, labeling, and warehousing facilities and avoid problems such as product adulteration, product mix-up, label mix-up, and misbranding.

Hot-Melt Developments

Developments in hot-melt extrusion using twin-screw extruders to make solid-dosage drug forms.
Jul 2, 2012

Developments in hot-melt extrusion using twin-screw extruders to make solid-dosage drug forms.

35th Anniversary Special: Breakthroughs and Emerging Technologies in Manufacturing

Industry experts share their insight on solid-dosage and sterile manufacturing.
Jul 2, 2012

Industry experts share their insight on solid-dosage and sterile manufacturing.

Teva Wins Patent-infringement Lawsuit Protecting Copaxone

Jun 25, 2012

US court ruled in favor of Teva in its patent-infringement lawsuit against Momenta and Mylan's generic versions of Teva's Copaxone.

Finding Value in Single-use Systems

Time- and cost-savings benefits help drive increased use of single-use, disposable systems in biopharmaceutical manufacturing.
Jun 20, 2012

Time- and cost-savings benefits help drive increased use of single-use, disposable systems in biopharmaceutical manufacturing.

Pharma Associations Provide Update on Anticounterfeiting Initiatives

Jun 11, 2012

European and US associations call for continued vigilance against the threat of counterfeit medicines.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here